Recent Quotes
My Watchlist
Indicators
Local Stocks
NewsOK Local Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

CytomX Therapeutics, Inc. - Common Stock (NQ:CTMX)

0.7443 +0.0927 (+14.23%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,656,247
Open 0.6516
Bid (Size) 0.7130 (8)
Ask (Size) 0.7450 (1)
Prev. Close 0.6516
Today's Range 0.6250 - 0.7443
52wk Range 0.4000 - 5.850
Shares Outstanding 66,767,779
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Curious about the stocks that are showing activity after the closing bell on Monday?
The US market regular session of Monday is over, let's have a look at the top gainers and losers in the after hours session today. 
Via Chartmill
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga

Performance

YTD
-29.8%
-29.8%
1 Month
+17.1%
+17.1%
3 Month
-9.2%
-9.2%
6 Month
-25.0%
-25.0%
1 Year
-54.3%
-54.3%

More News

Read More
Which stocks have an unusual volume on Monday?
Via Chartmill
Friday's pre-market session: top gainers and losers
Via Chartmill
(CTMX) - Analyzing CytomX Therapeutics's Short Interest
Via Benzinga
Why Gap Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
CTMX Stock Earnings: CytomX Therapeutics Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
Buy Alert: 3 Penny Stocks That Will Explode in 2024
Via InvestorPlace
Earnings Scheduled For March 6, 2025
Via Benzinga
No Memes, Ma’am! Try a Sensible Biotech Bet With CytomX Therapeutics Stock.
Via InvestorPlace
Analysts' Varied Perspectives On CytomX's CX-904 Cancer Study: Safety Profile But Caution in Pancreatic Cancer
Via Benzinga
Gold Moves Higher; Roblox Issues Weak Outlook
Via Benzinga
SOUN Stock Alert: SoundHound AI Announces New Partnership With Perplexity
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Dear NVDA Stock Fans, Mark Your Calendars for June 2
Via InvestorPlace
Why Duolingo Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Dow Jumps Over 150 Points; US Foods Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
Why Is CytomX (CTMX) Stock Down 43% Today?
Via InvestorPlace
Why AppLovin Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
CTMX Stock Earnings: CytomX Therapeutics Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Breaking on The Street Stocks To Watch Now! CTMX, PRSO, IMCC, KAVL, VTAK
Via AB Newswire

Frequently Asked Questions

Is CytomX Therapeutics, Inc. - Common Stock publicly traded?
Yes, CytomX Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does CytomX Therapeutics, Inc. - Common Stock trade on?
CytomX Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for CytomX Therapeutics, Inc. - Common Stock?
The ticker symbol for CytomX Therapeutics, Inc. - Common Stock is CTMX on the Nasdaq Stock Market
What is the current price of CytomX Therapeutics, Inc. - Common Stock?
The current price of CytomX Therapeutics, Inc. - Common Stock is 0.7443
When was CytomX Therapeutics, Inc. - Common Stock last traded?
The last trade of CytomX Therapeutics, Inc. - Common Stock was at 04/30/25 04:00 PM ET
What is the market capitalization of CytomX Therapeutics, Inc. - Common Stock?
The market capitalization of CytomX Therapeutics, Inc. - Common Stock is 49.70M
How many shares of CytomX Therapeutics, Inc. - Common Stock are outstanding?
CytomX Therapeutics, Inc. - Common Stock has 50M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.